Royalty Pharma Sub-Manager, LLC
New York, NY · CIK 2081668 · 13F filing filed 2026-08-21
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityRoyalty Pharma Sub-Manager, LLC (US)
- Part of ROYALTY PHARMA PLC (GB)
Other 13F filers in this group: Royalty Pharma plc files a notice
- Others nearbyNew York, NY
- FamilyRoyalty Pharma plc · 2 related pages · largest: Royalty Pharma plc
$241.9m
reported value
+40.0% vs Q1 2026
4positions
100.0%in top 10
1 new
0 added
0 reduced
1 sold out
vs Q1 2026
This report includes the holdings of 2 other managers that share the investment decisions:
- Royalty Pharma Manager, LLC – reports through this filing
- Royalty Pharma plc – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CYTOKINETICS INC CYTK | $83.5m34.52% | Unchanged |
| ZENAS BIOPHARMA INC ZBIO | $60.6m25.05% | Unchanged |
| KAILERA THERAPEUTICS INC KLRA | $54.1m22.36% | New |
| BIOHAVEN LTD BHVN | $43.7m18.06% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| BIOCRYST PHARMACEUTICALS INC BCRX | $36.6m3.8m shares |